$SOPH ($SOPH) posted quarterly earnings results for Q3 2026 on Tuesday, November 3rd. The company reported earnings of -$0.24 per share, missing estimates of -$0.19 by $0.05. The company also reported revenue of $24,270,000, missing estimates of $24,515,700 by $-245,700.
You can see Quiver Quantitative's $SOPH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
$SOPH Insider Trading Activity
$SOPH insiders have traded $SOPH stock on the open market 82 times in the past 6 months. Of those trades, 1 have been purchases and 81 have been sales.
Here’s a breakdown of recent trading of $SOPH stock by insiders over the last 6 months:
- JURGI CAMBLONG (Executive Chairman) has made 0 purchases and 22 sales selling 346,831 shares for an estimated $2,216,323.
- ZHENYU XU (Chief Scientific Officer) has made 0 purchases and 16 sales selling 95,395 shares for an estimated $699,113.
- PHILIPPE MENU (Chief Medical Officer) has made 0 purchases and 12 sales selling 60,395 shares for an estimated $387,432.
- ABHIMANYU VERMA (Chief Technology Officer) has made 0 purchases and 6 sales selling 30,569 shares for an estimated $227,657.
- ROSS MUKEN (Chief Executive Officer) has made 0 purchases and 5 sales selling 21,281 shares for an estimated $140,612.
- KATHY L HIBBS has made 0 purchases and 3 sales selling 20,008 shares for an estimated $140,087.
- MANUELA VALENTE (Chief People Officer) has made 0 purchases and 4 sales selling 18,861 shares for an estimated $137,103.
- GEORGE CARDOZA (Chief Financial Officer) has made 1 purchase buying 20,000 shares for an estimated $99,000 and 4 sales selling 4,732 shares for an estimated $31,928.
- WELL DAAN VAN (Chief Legal Officer) has made 0 purchases and 3 sales selling 13,020 shares for an estimated $100,338.
- KEVIN PUYLAERT (Chief Sales Officer) has made 0 purchases and 6 sales selling 465 shares for an estimated $2,973.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SOPH Hedge Fund Activity
We have seen 39 institutional investors add shares of $SOPH stock to their portfolio, and 24 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AIGH CAPITAL MANAGEMENT LLC removed 2,264,799 shares (-57.3%) from their portfolio in Q3 2026, for an estimated $18,979,015
- AMERIPRISE FINANCIAL INC added 2,216,752 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,790,659
- AWM INVESTMENT COMPANY, INC. added 1,700,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,809,000
- ROYCE & ASSOCIATES LP added 1,565,424 shares (+86.2%) to their portfolio in Q2 2026, for an estimated $9,032,496
- SILVERCREST ASSET MANAGEMENT GROUP LLC added 1,428,470 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,242,271
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 285,000 shares (-15.4%) from their portfolio in Q2 2026, for an estimated $1,644,449
- ARCHON CAPITAL MANAGEMENT LLC added 250,000 shares (+56.6%) to their portfolio in Q2 2026, for an estimated $1,442,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.